In mouse models, the TIGIT and PD-1 pathways are mechanistically interdependent, and co-blockade of TIGIT and PD-L1 has been shown to synergistically elicit anti-tumour T cell responses9,10. This evidence concerns the gene PDCD1 and neoplasm.